Further Information Disclaimer
Home
Referring Centers
For Patients
Publications
disclaimer

1/15/2010 - Reprogenetics is proud to offer array CGH to detect all chromosome aneuploidies. As of 2/1/2010 the price has change to a reduced flat fee with NO CANCELLATION FEE.

1/5/2010 - We have proven that although microarray technology can detect all aneuploidies in embryos, the simpler and cheaper FISH test, if modified, can detect up 90% of them. | Read

1/3/2010 - Reprogenetics shows in a publication in press that PGD for patients with translocations and recurrent pregnancy loss benefit from PGD by increasing their odds at keeping their pregnancies to term. | Read

1/1/2010 - Reprogenetics clinical results with comparative Genome hybridization are now in press. This technique allows for the analysis of all chromosome aneuploidies. | Read
PGD BREAKING NEWS

8/20/2009 - Scientists from Reprogenetics demonstrate a reduction in miscarriages after PGD in patients at risk of recurrent pregnancy loss. | Read

1/1/2010 - Scientists from Reprogenetics explain why PGD for aneuploidy works in some centers and not others: it’s the experience and the techniques used. |2009 paper rebuttal|2009 review rebuttal

11/1/2009 - Reprogenetics reports its results of PGD for the analysis of Gene Defects, such as Cystic fibrosis, Thalassemia, Breast cancer (BRCA), fragile X, Gaucher disease, Huntington disease, Neurofibromatosis, sickle cell anemia, Tay sachs and 58 other disease. | Read

7/29/2009 - Reprogenetics is proud to announce its 15,000th procedure for chromosome analysis of embryos.

8/20/2009 - Dr. Colls, at Reprogenetics, publishes the results of the PGD test with 12 probes, showing equal error rate than 9 probes but detecting more chromosome abnormalities in embryos. | Read


PGD DIAGNOSIS
Reprogenetics provides PGD analysis to IVF centers, including PGD of aneuploidy for advanced maternal age (such as Down syndrome), repeated IVF failure, recurrent spontaneous abortions, chromosome translocations and inversions, as well as PGD for gene defects such as Cystic fibrosis, fragile X, Myotonic Dystrophy, Thalasaemia, Tay Sachs, and others. We also provide embryologist that can perform embryo biopsy and cell processing.  
GENETIC COUNSELING FOR PATIENTS
Patients interested in PGD services could contact an IVF center for which we provide services or directly contact our genetic counselor for an in depth discussion of your case.
ASSOCIATIONS
www.IVFonline.com
www.LifeGlobal.com
www.ivflabs.com


MORE STORIES
Reprogenetics obtains a license to perform PGD in NY state for any type of PGD
Dear Colleague: In July of 2003, laboratories and assisted reproductive technology (ART) providers were notified that a New York State laboratory permit would be required for facilities performing preimplantation genetic diagnosis (PGD) on single cells derived from embryos by molecular genetic and/or cytogenetic techniques. | Read

10.15.2007 - Empire Genomics and Reprogenetics join forces to improve Preimplantation Genetic Diagnosis (PGD)
Read

07. 05.2007 -  World leading PGD experts are issuing a rebuttal to an article on preimplantation genetic diagnosis (PGD)
Read

07.15, 2007 - A report by Colls et al. of Reprogenetics shows a significant reduction of spontaneous abortions and an increase in pregnancies reaching term after using PGD with "no Result rescue"
Read
Microarray technology to assess gene expression profiles of human oocytes and embryos. Introduction: The current knowledge of molecular mechanisms during early development is pretty rudimentary.   | Read
Results of PGD for infertility in 3597 cycles
Introduction: Preimplantation genetic Diagnosis of aneuploidy, has been offered clinically since 1993, but it is not until the   last few years that    through the use of reference PGD laboratories, the technique is available to all USA-based IVFcenters.  | Read
Maternal age is the most important parameter predicting aneuploidy yet it is an unpredictable indicator of chromosome abnormalities
Introduction: The increase of aneuploidy with maternal age has been demonstrated both with live birth, fetus, embryos   and oocyte data.  | Read
The importance of a full chromosome count in PGD
PGD-AS using FISH is limited by the number of chromosomes that can be analysed.  | Read
Full Karyotype Interphase Cells Analysis
Early human development depends on the correct temporal and spatial expression of thousands of genes. | Read  
Restrictive art laws and PGD
Introduction: It is an irony that in some countries such as Germany and Italy multiple pregnancy and embryo   cryopreservation have   been artificially diminished by restrictive laws limiting the number of eggs inseminated. | Read
Preimplantation genetic diagnosis (PGD) for chromosome structural aberrations: Outcome  and comparison
 Introduction: Since 1995, Reprogenetics has performed over 4,500 PGD cycles.  | Read
Embryonic chromosome abnormalities
The presence of numerical chromosome abnormalities in human embryos was studied using fluorescence in situ   hybridization with up to 9 chromosome specific probes.  |Read
2/2006 High rates of chromosome abnormalities are found in embryos from egg donors, suggesting that PGD may be recommended in egg donor cycles.
Embryo chromosome studies show high rates of abnormalities, above 50%, but most embryos studied before this study were from patients 35 and older. | Read
1/2006: PGD significantly reduces the risk of pregnancy loss after IVF
The incidence of miscarriage is correlated with maternal age. The majority of the miscarriages are chromosomally abnormal. | Read
Reprogenetics demonstrates that patients with recurrent pregnancy loss can benefit from PGD
The objective of the study was to determine if Preimplantation Genetic Diagnosis (PGD) and transfer of chromosomally normal embryos would decrease spontaneous abortion rates in patients suffering from recurrent pregnancy loss (RPL).   | Read
HOME >>>
 

Reprogenetics
© Copyright 2001 Janus Net Technology, Inc. All rights reserved.
Refering IVF Centers Contact Us Further Information Disclaimers about PGD